Cash & equivalents decreased 93.4%
Cash & equivalents changed -93.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.1M→$75,0004 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CLRO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities decreased 87.6%
Current liabilities changed -87.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$7.5M→$929,0004 prior comparisons
Current assets decreased 94.2%
Current assets changed -94.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$16.9M→$976,0004 prior comparisons
Total assets decreased 95.9%
Total assets changed -95.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$24.0M→$990,0004 prior comparisons
Working capital decreased 99.5%
Working capital changed -99.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$9.4M→$47,0004 prior comparisons
Shares outstanding increased 54.3%
Shares outstanding changed +54.3% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
1,734,249→2,675,4128 prior comparisons
Net income increased 80.0%
Net income changed +80.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$4.6M→-$914,0003 prior comparisons
Operating income increased 79.8%
Operating income changed +79.8% from the comparable as-filed period.
-$4.6M→-$919,0003 prior comparisons
Working capital / assets moved 3429 bp lower
Working capital / assets changed -3429 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
39.03%→4.75%4 prior comparisons
Gross profit increased 69.7%
Gross profit changed +69.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$231,000→-$70,0003 prior comparisons
Research & development decreased 100.0%
Research & development changed -100.0% from the comparable as-filed period.
$1.4M→$03 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.